Metabasis Completes Enrollment Of Its Proof-of-Concept Clinical Trial For MB07803, Its Product Candidate For The Treatment Of Type 2 Diabetes

Monday, March 3rd, 2008

Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced the completion of patient enrollment in its Phase 2a clinical trial for MB07803, a product candidate being studied as a treatment for patients with type 2 diabetes. With this trial fully enrolled and the final patients undergoing dosing, the Company expects to be able to ...

Posted in Diabetes | No Comments »

Artisan Pharma’s Lead Product, ART-123, Approved In Japan

Monday, February 25th, 2008

Artisan Pharma, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency approved Artisan's lead drug, ART-123 (human, soluble, recombinant thrombomodulin), on January 25, 2008 for the treatment of disseminated intravascular coagulation ("DIC") in Japan. The approval of ART-123, which was received by Artisan's partner and licensor of ART-123, Asahi Kasei ...

Posted in Blood / Hematology | No Comments »

ATS Medical Announces Initial Clinical Results Of Stand Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line

Saturday, February 23rd, 2008

ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products, announced initial clinical results of stand-alone ablation procedures and an overall expansion into the stand-alone market, using the ATS CryoMaze(TM) product line. This line of surgical products, indicated for the treatment of cardiac arrhythmias, is designed to ...

Posted in Cervical Cancer | No Comments »

Breast Care Solutions By Siemens Offer A Comprehensive Product Spectrum For The Diagnosis And Therapy Of Breast Cancer

Tuesday, February 19th, 2008

Among women, breast cancer is the most common cause of cancer death. Each year nearly 180,000 women in the United States are diagnosed with breast cancer. More than 40,000 a year die from this disease*. These facts stress the importance of a quality-ensured early detection of breast cancer as well ...

Posted in Breast Cancer | No Comments »

AOptix Technologies Adds VP Of Operations To Launch Advanced Biometrics Iris Product

Monday, February 18th, 2008

AOptix Technologies, Inc., a leading edge developer of advanced iris recognition and ultra-high bandwidth laser communication systems, announces the hiring of Doug McNeil as Vice President of Operations. Prior to joining AOptix, Doug was VP of Engineering for Visyx, where he served since its formation in 2006. He was responsible for ...

Posted in Pharma Industry | No Comments »